Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin
Hematol., Transfus. Cell Ther. (Impr.)
; 41(4): 356-359, Oct.-Dec. 2019. ilus
Article
in En
| LILACS
| ID: biblio-1056239
Responsible library:
BR408.1
Localization: BR408.1
Full text:
1
Index:
LILACS
Main subject:
Hematopoiesis, Extramedullary
/
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
/
Inotuzumab Ozogamicin
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2019
Type:
Article